Navigation section

Marksans Pharma Limited

Marksans Pharma Limited

Performance

Today's Low Today's High
276.00 276.20
280.99 280.95
52 Week Low 52 Week High
97.45 (26-Oct-2023) 97.60 (26-Oct-2023)
298.94 (18-Sep-2024) 298.70 (18-Sep-2024)
Open
276.00 277.45
Previous Close
274.44 274.25
Volume
2.30
Total Traded value
6.41 (₹ Lakhs)
Upper circuit
329.32 195.70
Lower circuit
219.55 130.50

Market Depth

Buy Order Quantity Sell Order Quantity
94,663
 185,356
Bid PriceQuantity
280.101,100.00
280.041.00
280.0326.00
280.02172.00
280.01122.00
Total:94,663
Ask PriceQuantity
280.302,000.00
280.3128.00
280.3255.00
280.3695.00
280.3912.00
Total:185,356

Fundamentals

Market Cap: ₹126.94 Cr
PE Ratio (TTM): 102.22
PB Ratio: 10.16
Industry P/E:38.21
Debt to Equity:-
ROE:9.94
EPS (TTM):2.68
Book Value:0.00
Face Value: 1.00

Financials

Dec, 2022Sep, 2022Mar, 2023Sep, 2023Sep, 2022
Revenue15,228.00 Cr351.10 Cr135.83 Cr358.51 Cr170.26 Cr
Profit2,505.00 Cr37.70 Cr-9.61 Cr13.03 Cr40.23 Cr
Expense11,977.00 Cr321.00 Cr148.91 Cr342.66 Cr142.31 Cr
Comprehensive income2,536.00 Cr37.30 Cr-9.44 Cr13.42 Cr40.24 Cr
EPS10.672.07-1.338.021.00
Marksans Pharma Limited, along with its subsidiaries, is involved in the global research and development, manufacturing, marketing, and distribution of generic pharmaceutical formulations. The company offers a wide range of products in various therapeutic areas such as analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension. Established in 1992, Marksans Pharma Limited is headquartered in Mumbai, India.
Company nameListing dateIndustry NSE symbol BSE symbol
Marksans Pharma Limited Jan, 2002 Feb, 1994 Pharmaceuticals Pharmaceuticals MARKSANS MARKSANS

Shareholding pattern

Sep, 2023 Jun, 2023 Mar, 2023 Jan, 2023 Dec, 2022

  • Promoters 
    		 43.85%
    Public 
    		 56.15%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.85%
    Public 
    		 56.15%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.85%
    Public 
    		 56.15%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 43.80%
    Public 
    		 56.20%
    Shares held by Employee Trusts 
    		 0.00%
  • Promoters 
    		 49.00%
    Public 
    		 51.00%
    Shares held by Employee Trusts 
    		 0.00%

Marksans Pharma Limited FAQ's

What is the range of today's stock performance for Marksans Pharma Limited?

Today's stock performance witnessed a fluctuation from a minimum of 276.00 on the NSE (National Stock Exchange) to a maximum of 280.99. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 276.20 to a high of 280.95.

What are the 52-week low and high values for Marksans Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 97.45 (occurred on 26-Oct-2023) and a high of 298.94 (achieved on 18-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 97.60 (on 26-Oct-2023), and the 52-week high is 298.70 (on 18-Sep-2024).

What was the opening and previous closing prices for Marksans Pharma Limited?

The stock's performance over the past 52 weeks reveals a low of 97.45 (occurred on 26-Oct-2023) and a high of 298.94 (achieved on 18-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 97.60 (on 26-Oct-2023), and the 52-week high is 298.70 (on 18-Sep-2024).

What is the total volume and traded value for Marksans Pharma Limited for the day?

The total volume is 2, and the total traded value is 6.41 (₹ Lakhs).

What are the upper and lower circuit limits for Marksans Pharma Limited?

The upper circuit limit is 329.32, and the lower circuit limit is 219.55.

What is the market cap and PE ratio for Marksans Pharma Limited?

The market cap is ₹126.94 Cr, and the PE ratio (TTM) is 38.21.

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Marksans Pharma Limited?

ROE is 9.94, EPS is 2.68, book value is not available

What are the revenue and profit figures for the latest quarter and previous quarters for Marksans Pharma Limited?

In Dec 2022, Revenue is ₹152280000000.00, and Profit is ₹25050000000.00. In Sep 2022, Revenue is ₹3511000000, and Profit is ₹377000000.

When was Marksans Pharma Limited listed, and what industry does it belong to?

The company, Marksans Pharma Limited, was listed in Jan 2002 and belongs to the Pharmaceuticals industry. Its NSE symbol is MARKSANS.

What is the current shareholding pattern of the Marksans Pharma Limited?

As of latest available update, promoters hold 43.85%, the public holds 56.15%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
18
online
1876
Threads
33
Settings

Latest Business News

Share this stock

Back
Top